Please wait

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Name of Issuer)

(Title of Class of Securities)

(CUSIP Number)

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

X0202 SCHEDULE 13D/A 0001493152-26-033090 0002134293 XXXXXXXX LIVE 3 Common Stock, par value $1 per share 09/08/2026 false 0001770450 98421M106 Xerox Holdings Corp P.O. Box 4505, 401 Merritt 7 Norwalk CT 06851-1059 Frantisek Bostl 420-604-215-002 Plynarni 1617/10, Prague 7 2N 17000 0002134293 N STARTEEPO SICAV a.s. a OO N 2N 0.00 8000000.00 0.00 8000000.00 8000000.00 N 6.09 OO Row 13: Based on 131,314,511 shares of Common Stock outstanding as of July 31, 2026, as reported in the Issuer's Quarterly Report on Form 10-Q for the period ended June 30, 2026, as filed with the Securities and Exchange Commission (the "SEC") on August 6, 2026. 0002134654 N Frantisek Bostl a PF N 2N 1640000.00 8000000.00 1640000.00 8000000.00 9640000.00 N 7.34 IN Row 7, Row 9, and Row 11: Consists of (i) 1,500,000 shares of Common Stock and (ii) 140,000 shares of Common Stock underlying call options, as described in Item 6, held directly by Mr. Bostl. Row 8, Row 10, and Row 11: Represents 8,000,000 shares of Common Stock held of record by the Fund for which Mr. Bostl may be deemed to be a beneficial owner as the Chief Investment Officer and Chairman of the Board of Directors of the Fund and owner of all of the voting shares of the Fund. Mr. Bostl disclaims beneficial ownership of the Common Stock held by the Fund except to the extent of his direct pecuniary interest therein. Row 13: Based on 131,314,511 shares of Common Stock outstanding as of July 31, 2026, as reported in the Issuer's Quarterly Report on Form 10-Q for the period ended June 30, 2026, as filed with the SEC on August 6, 2026. Common Stock, par value $1 per share Xerox Holdings Corp P.O. Box 4505, 401 Merritt 7 Norwalk CT 06851-1059 This Amendment No. 3 ( this "Amendment No. 3") to the Schedule 13D is being filed by (i) STARTEEPO SICAV a.s. (formerly known as STARTEEPO Invest, investicni fond s promennym zakladnim kapitalem, a.s.) (the "Fund") and (ii) Frantisek Bostl (collectively, the "Reporting Persons", and each, a "Reporting Person") to amend the Schedule 13D filed by the Reporting Persons with the Securities and Exchange Commission (the "SEC") on May 14, 2026, as amended on June 3, 2026 and July 13, 2026 (the "Schedule") with respect to the Reporting Persons' holdings of common stock, $1 par value per share (the "Common Stock") of Xerox Holdings Corporation (the "Issuer"). This Amendment No. 3 amends and restates Items 2(a)-(b), 3, 5(a)-(c) and 6 and supplements Item 4 and Item 7 of the Schedule as set forth below. Unless otherwise indicated, all capitalized terms used and not defined herein have the respective meanings assigned to them in the Schedule. This Schedule is filed on behalf of (i) STARTEEPO SICAV a.s. (formerly known as STARTEEPO Invest, investicni fond s promennym zakladnim kapitalem, a.s.) and (ii) Frantisek Bostl. The address of the principal business and principal office of each of the Reporting Persons is c/o STARTEEPO SICAV a.s., V parku 2308/8, Prague 4, Czech Republic 14800. All of the securities reported herein were purchased by the applicable Reporting Persons for an aggregate purchase price of $23,154,307, comprised of (i) $22,962,307 paid for shares of Common Stock and (ii) $192,000 paid in premiums for call options purchased by Mr. Bostl. The Common Stock held by the Fund was purchased in the open market with working capital of the Fund. The Common Stock and call options held by Mr. Bostl were purchased in the open market with his personal funds. The Reporting Persons have increased their investment based on their belief that the Common Stock is undervalued and represents an attractive investment opportunity. On September 7, 2026, the Reporting Persons issued an open letter (the "September Letter") to the Issuer's Board of Directors. In the September Letter, the Reporting Persons acknowledged the Issuer's operational and financial progress, but expressed concern that the Issuer remains deeply undervalued. The Reporting Persons urged the Board of Directors to provide more detailed financial reporting on Xerox Financial Services ("XFS") and to engage financial advisors to conduct a formal strategic review of XFS, evaluating all available alternatives to unlock value, including a joint venture, capital partnership, partial monetization, or sale. The foregoing summary does not purport to be complete and is qualified in its entirety by reference to the full text of the September Letter, attached hereto as Exhibit 99.7 and incorporated herein by reference. The Reporting Persons may engage in discussions with the Issuer's management, board of directors, other stockholders of the Issuer and other relevant parties concerning the business, operations, board composition, management, strategy and future plans of the Issuer. The Reporting Persons intend to re-examine their investment from time to time and, depending on prevailing market conditions, other investment opportunities, liquidity requirements or other investment considerations the Reporting Persons deem material, the Reporting Persons may from time to time acquire additional Common Stock in the open market, block trades, negotiated transactions, or otherwise and may also dispose of all or a portion of the Issuer's securities, in open market or privately negotiated transactions, and/or enter into derivative transactions with institutional counterparties with respect to the Issuer's securities. The Reporting Persons have not yet determined which, if any, of the above courses of action they may ultimately take. The Reporting Persons' future actions with regard to the Issuer are dependent on their evaluation of the factors listed above, circumstances affecting the Issuer in the future, including prospects of the Issuer, general market and economic conditions and other factors deemed relevant. The Reporting Persons reserve the right to determine in the future whether to change the purpose or purposes described above or whether to adopt plans or proposals of the type specified above or otherwise. Except as set forth in the preceding paragraphs, as of the date hereof, the Reporting Persons do not have any plan or proposal that relates to or would result in any of the transactions enumerated in sub items (a) through (j) of Item 4 of Schedule 13D. The responses of each of the Reporting Persons with respect to rows (11) and (13) of the cover pages to this Schedule that relate to the aggregate number of shares of Common Stock and percentage of the shares of Common Stock beneficially owned by each of the Reporting Persons (including without limitation, the footnotes thereto) are incorporated by reference into this Item 5(a). The percentage used in this Schedule is calculated based upon 131,314,511 shares of Common Stock outstanding as of July 31, 2026, as reported in the Issuer's Quarterly Report on Form 10-Q for the period ended June 30, 2026, as filed with the SEC on August 6, 2026. The responses of each of the Reporting Persons with respect to rows (7) through (10) of the cover pages to this Schedule that relate to the number of shares of Common Stock as to which each of the Reporting Persons has sole or shared power to vote or to direct the vote of and sole or shared power to dispose of or to direct the disposition of (including, without limitation, the footnotes thereto) are incorporated herein by reference into this Item 5(b). All transactions of the Reporting Persons in the Common Stock effected since the filing of the Schedule are set forth on Exhibit 99.6 hereto and that information is incorporated by reference herein. The Reporting Persons have entered into a Joint Filing Agreement dated as of September 8, 2026, a copy of which is filed herewith as Exhibit 99.5. Exhibit 99.5 Joint Filing Agreement, dated as of September 8, 2026, by and among the Reporting Persons Exhibit 99.6 Trading Data Exhibit 99.7 September Letter, dated September 7, 2026 STARTEEPO SICAV a.s. /s/ Frantisek Bostl Chief Investment Officer and Chairman of the Board 09/08/2026 Frantisek Bostl /s/ Frantisek Bostl Frantisek Bostl 09/08/2026